4MMQ

Crystal Structure of Prefusion-stabilized RSV F Variant DS


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.253 Å
  • R-Value Free: 0.274 
  • R-Value Work: 0.237 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.

McLellan, J.S.Chen, M.Joyce, M.G.Sastry, M.Stewart-Jones, G.B.Yang, Y.Zhang, B.Chen, L.Srivatsan, S.Zheng, A.Zhou, T.Graepel, K.W.Kumar, A.Moin, S.Boyington, J.C.Chuang, G.Y.Soto, C.Baxa, U.Bakker, A.Q.Spits, H.Beaumont, T.Zheng, Z.Xia, N.Ko, S.Y.Todd, J.P.Rao, S.Graham, B.S.Kwong, P.D.

(2013) Science 342: 592-598

  • DOI: 10.1126/science.1243283
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site Ø, a m ...

    Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site Ø, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is targeted by extremely potent RSV-neutralizing antibodies. Structure-based design yielded stabilized versions of RSV F that maintained antigenic site Ø when exposed to extremes of pH, osmolality, and temperature. Six RSV F crystal structures provided atomic-level data on how introduced cysteine residues and filled hydrophobic cavities improved stability. Immunization with site Ø-stabilized variants of RSV F in mice and macaques elicited levels of RSV-specific neutralizing activity many times the protective threshold.


    Organizational Affiliation

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Fusion glycoprotein F2
A
82Human respiratory syncytial virus A (strain A2)Mutation(s): 1 
Gene Names: F
Find proteins for P03420 (Human respiratory syncytial virus A (strain A2))
Go to UniProtKB:  P03420
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Fusion glycoprotein F1 fused with Fibritin trimerization domain
B
414Human respiratory syncytial virus A (strain A2)Enterobacteria phage T4
This entity is chimeric
Mutation(s): 4 
Gene Names: F, wac
Find proteins for P03420 (Human respiratory syncytial virus A (strain A2))
Go to UniProtKB:  P03420
Find proteins for P10104 (Enterobacteria phage T4)
Go to UniProtKB:  P10104
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
SO4
Query on SO4

Download SDF File 
Download CCD File 
A, B
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.253 Å
  • R-Value Free: 0.274 
  • R-Value Work: 0.237 
  • Space Group: P 41 3 2
Unit Cell:
Length (Å)Angle (°)
a = 168.442α = 90.00
b = 168.442β = 90.00
c = 168.442γ = 90.00
Software Package:
Software NamePurpose
SERGUIdata collection
PHASERphasing
PHENIXrefinement
HKL-2000data scaling
HKL-2000data reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2013-11-20
    Type: Initial release
  • Version 1.1: 2017-07-26
    Type: Refinement description, Source and taxonomy